Increased SNX20 and PD-L1 Levels Can Predict the Clinical Response to PD-1 Inhibitors in Lung Adenocarcinoma
Linwei Fan,* Li Li,* Chunye Huang, Shanshan Huang, Jun Deng, Jianping Xiong Department of Oncology, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi Province 330006, People’s Republic of China*These authors contributed equally to this workCorrespondence: Jun Deng; Ji...
Main Authors: | Fan L, Li L, Huang C, Huang S, Deng J, Xiong J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-10-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/increased-snx20-and-pd-l1-levels-can-predict-the-clinical-response-to--peer-reviewed-article-OTT |
Similar Items
-
SNX20AR/MiRNA-301a-3p/SNX20 Axis Associated With Cell Proliferation and Immune Infiltration in Lung Adenocarcinoma
by: Yixiao Yuan, et al.
Published: (2021-09-01) -
Membrane-remodeling by SNX18 in endosomal transport and autophagy
by: Håberg, Karin
Published: (2012) -
A Novel PD-L1-targeting Antagonistic DNA Aptamer With Antitumor Effects
by: Wei-Yun Lai, et al.
Published: (2016-01-01) -
Advances of PD-1/PD-L1 Inhibitors in Tumor Immunotherapy
by: Yong-jun LIU, et al.
Published: (2017-06-01) -
Immune classification for the PD-L1 expression and tumour-infiltrating lymphocytes in colorectal adenocarcinoma
by: Byeong-Joo Noh, et al.
Published: (2020-01-01)